[Federal Register: January 22, 1999 (Volume 64, Number 14)]
[Notices]               
[Page 3530-3531]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22ja99-89]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Advisory Council on Drug Abuse.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign

[[Page 3531]]

language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets of commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: February 2-3, 1999.
    Closed: February 2, 1999, 2:00 pm to 5:00 pm
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building 45, 45 
Center Drive, Bethesda, MD 20892.
    Open: February 3, 1999, 9:00 am to Adjournment.
    Agenda: This portion of the meeting will be open to the public 
or announcements and reports of administrative, legislative and 
program developments in the drug abuse field.
    Place: National Institutes of Health, Natcher Building 45, 45 
Center Drive, Bethesda, MD 20892.
    Contact Person: Teresa Levitin, Phd, Director, Office of 
Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, Bethesda, MD 10892, (301) 5554-
2755.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institute of Health, 
HHS)

    Dated: January 14, 1999.
LaVerne Y. Springfield,
Committee Management Officer, NIH.
[FR Doc. 99-1426 Filed 1-21-99; 8:45 am]
BILLING CODE 4140-01-M